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Abstract
Background: Ovine pregnancy toxaemia is a common metabolic disorder of ewes due to increased foetal energy
requirements in late pregnancy. This pathology is a metabolic condition characterized by hypoglycaemia and
hyperketonaemia resulting in the inability of the animal to maintain an adequate energy balance. The response to
treatment is effective, if it is started in the early stages of the disease, when irreversible neurological injuries have not
yet been established. The aim was to evaluate three therapeutic alternatives to effectively reverse the disease process
in its early stages.
For this, thirty adult Corriedale ewes, pregnant with a single lamb, were randomly separated in three groups of ten
animals each, at day 130 of gestation. From that day onwards, ewes were locked up for forage fasting until glycaemia
reached clinical values defining sub-clinical pregnancy toxaemia (1.59 ± 0.24 mmol/L). After fasting, ewes grazed and
received a treatment for 4 days: 50 ml i.v. infusions of hypertonic glucose and 20 UI insulin/ewe/day s.c. or 100 ml/
sheep/12 h of glycerol together with propylene glycol oral solution or fed with pasture supplemented with two daily
intakes 300 g/sheep of cracked corn. Glycaemia and ß-hydroxybutyrate were determined in all the animals from the
beginning of fasting until the completion of the treatment.
Results: Fasting caused a decline in blood glucose in the 3 groups. This decline continued until fasting was withdrawn
and treatment began. Thereafter blood glucose increased in all three groups, although in the group supplemented
with glycerol and propylene glycol it started to increase significantly after 12 h. The values of ß-hydroxybutyrate
decreased in the 3 groups at the start of treatment, and this decline was more pronounced earlier on and in the group
supplemented with glycerol and propylene glycol. We found no significant differences between all experimental
groups. No animal showed clinical signs of pregnancy toxaemia throughout the research.
Conclusions: The three treatments administered to sheep affected by sub-clinical pregnancy toxaemia were able to
restore normal concentration of glucose and ß-hydroxybutyrate in blood, although per os administration of 100 ml/
sheep/12 h of glycerol with propylene glycol, was the most successful treatment, normalizing the aforementioned
biochemical parameters in a shorter time.
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Background
Ovine pregnancy toxaemia (OPT) is a common metabolic
disorder of undernourished ewes due to increased foetal
energy requirements in late pregnancy [1]. This pathology
is characterised by hypoglycaemia and hyperketonaemia
resulting in the inability of the animal to maintain an
adequate energy balance [2–5]. The disease has a significant
economic impact on sheep and goat enterprises due to loss
of sheep and foetuses; veterinary costs and dam balance
[3–7]. The disease has been associated to multiple gestation
[2, 7–9], but it can be found in ewes carrying a singleton,
when winters are rigorous and nutritional deficiencies
occur [10, 11] or during periods of starvation after excessive
fatness [8, 12] .
It has been shown that fasting causes a rapid triacylgly-
cerides (TAG) mobilization from adipose tissue, which is
reflected in the rapid rise of non-esterified fatty acids
(NEFA) values representing earlier blood changes in sheep
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under fasting. This increase in lipid mobilization leads to a
high incidence of hepatic steatosis in these animals [10, 13].
One of the most important and measurable factors
to determine whether a sheep suffers the disease or
not, is the evaluation of the hepatic function. The liver
is important for the blood glucose metabolism, for the
glucose’s tissue supply and because it is virtually the
only organ where the gluconeogenesis takes place;
although there are small contributions from the
kidney [5, 9, 12].
Early detection of OPT in susceptible animals is therefore
essential for a successful treatment [10, 14]. Treatments
described for pregnancy toxaemia outcomes vary and turn
out to be costly when the disease affects a high number of
animals. The response to treatment is effective, if started
in the early stages of the disease, when irreversible neuro-
logical injuries have not been established, and when the
animal is not yet in decubitus [10, 12, 15]. An early disease
diagnosis is important, because it will allow a rational and
effective treatment [10]. The priority objective in the treat-
ment of the disease is to increase the formation of glucose
and its utilization at tissue level, and it must also increase
the use of the ketone bodies; which to solve or minimise
the acidosis and hydroelectrolytics disorders [12].
The aim of this work was to test three therapeutic
alternatives to effectively reverse the disease process
in early stages for application in extensive sheep
production systems where the cost/benefit ratio is
extremely important.
Methods
Fifty-five Corriedale adult ewes aged 4–6 years were
randomly selected from a flock under usual extensive
production conditions. At the beginning of the experi-
ment, all ewes were in similar physicial conditions;
scores were between 2.5 and 3.5 on a 1–5 scale [16]
and the mean bodyweight was 54.2 ± 5.7 kg. The
oestrous cycles of ewes were synchronized using intra-
vaginal devices with 60 mg of medroxiprogesterone
(Sincrovin, Santa Elena, Uruguay) inserted for 12 days,
and then the ewes were left with two fertile rams for
4 days until pregnancy was achieved. The mating date
was recorded as day 0 of gestation and was confirmed
with transabdominal ultrasonography between days 40
and 50 of gestation. Corriedale sheep mean gestational
length is reported to be 149 days [17]. Afterwards, 30
ewes carrying a single foetus were included in the protocol.
Sheep with a single foetus were chosen to avoid or minim-
ise the occurrence of spontaneous pregnancy toxaemia.
Ewes were grazed on pasture composed mainly by
Cynodon dactylon. Every 100 g of grass dry matter
provided 8.72 % crude protein and 1.86 Mcal EM/kg
dry matter metabolisable energy (Laboratory of
Nutrition Faculty of Veterinary Medicine, University
of la República, Uruguay).
On day 130 of gestation, sheep were randomly divided
into three groups: A, B and C of 10 animals each. From
this moment, sheep were penned in roofed paddocks
with a concrete floor and ad libitum access to water.
They were under total forage fasting until glycaemia
reached clinical values of sub-clinical pregnancy toxemia
(1.59 ± 0.24 mmol/L) [18]. After reaching these blood
glucose values, fasting was withdrawn individually; and
sheep were reintroduced into the natural pasture. All
sheep, and for 4 days, received the corresponding treatment
assigned to each group:
Firstly, group A (x = 55.75 ± 9.0 Kg) animals received
first 50 ml of 50 % i.v. infusions of hypertonic glucose
(Dextrolena®, Santa Elena, Uruguay) and lastly, in
addition, 20 UI subcutaneous insulin infusion, daily per
ewe (Caninsulin®, Intervet, Argentina). This treatment
was administered after the collection of blood samples
at 06:00 am.
Group B (x = 54.38 ± 8.5 Kg). Was administered to each
sheep every 12 h 100 ml of the oral solution Acetolena®
(Santa Elena, Uruguay), composed of 700 g of glycerol and
200 g of propylene glycol each liter. This treatment was
administered after blood samples collection at 06:00 am
and 06:00 pm.
Group C (x = 53.4 ± 8.1 Kg). After the collection of
blood samples, at 06:00 am and 06:00 pm each sheep
was fed two daily intakes of pasture supplemented with
300 g. of cracked corn.
Blood was collected by jugular venipuncture using an
18G needle attached to a 10 ml syringe. From confinement
(started on day 130 of pregnancy) and until treatment
completion all sheep were bled daily at 06:00 am to asses
ß-hydroxybutyrate (BOHB) and every 12 h (06:00 am and
06:00 pm) to determine glycaemia. Blood for glycaemia
determination was collected in tubes containing sodium
fluoride, while for BOHB determination blood was
collected in dry tubes. Glycaemia determination was
performed within two hours of the serum being collected,
and to determine BOHB frozen samples we stored at -
20 ° C in Eppendorf tubes properly labelled and identified
until processing.
We used Ranbut® commercial kits (Antrim, UK) and
Glucose Liquicolor® (Wiesbaden, Germany) for BOHB
and glycaemia determinations, with the aid of a digital
Humalyser Junior colorimeter at 37 °C, measuring 500
and 330 nm respectively.
The experimental procedures were conducted under
field conditions at the Faculty of Veterinary Medicine,
University of la Republica, Uruguay, located in Libertad,
Department of San José, Uruguay (34° 38’S; 56° 39´W),
upon approval of the local Animal Welfare Committee
(Honorary Committee for Animal Experimentation).
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Statistical analysis
Statistical analysis was carried out with Statistica 6.0
(Stat Soft Inc, Tulsa, OK, USA). Data distribution was
considered normal when p > α using the Shapiro-Wilk
test. ANOVA was used to evaluate statistical differences
between treatment groups for blood metabolites. When
differences were observed, a Tukey test was performed.
Differences were considered significant when p < 0.05.
Results
Three experimental groups were formed on day 130 of
pregnancy, glycaemia in the sheep did not show statistic
difference among the three groups. Average glycaemia for
groups A; B and C, at this stage, were: 2.71 ± 0.66; 2.95 ±
0.57 and 3.00 ± 0.57 mmol/L, respectively. Figure 1 shows
that glycaemia in the three groups started decreasing at 0 h
(fasting beginning). This decreasing continued for 36 h,
when the sheep stopped fasting, since all groups showed
glycaemia levels compatible with sub-clinical toxaemia,
showing no significant differences among groups at this
time (1.52 ± 0.49; 1.49 ± 0.54 y 1.64 ± 0.55 mmol/L, for
groups A, B y C, respectively).
Once the treatments started (48 h after treatment began)
glycaemia values rose in the three groups. In the sheep of
group B, glycaemia increased earlier and values were
higher than in the other groups throughout the treatment
(Fig. 1). Glycaemia in this group showed a significant
difference (p < 0.001) from glycaemia in group C, at 60 h
of confinement (12 h after treatment had started), and it
remained like this for 12 more hours, until 72 h (Table 1).
In comparison, glycaemia in group A increased earlier
than in group B, although this difference became signifi-
cant in samples taken at 72 h (24 h after the treatment
was implemented) (p < 0.0001). After 24 h treatment was
implemented in group A, these two groups showed sig-
nificant difference in glycaemia values, from this stage
until treatment completion, although they did not show
statistical difference in samples taken 12 h after treatment
implementation in group A (Table 1). When comparing
glycaemia in groups A and C, they only showed a sig-
nificant difference after 60 h (12 h after therapy started)
(p < 0.01), without showing differences until the last
sampling (p < 0.001) (Table 1).
BOHB values in sheep of the three groups, did not
show significant differences on day 130 of pregnancy,
average values in groups A; B and C were: 0.63 ± 0.39;
0.83 ± 0.53 and 0.87 ± 0.32 mmol/L, respectively. From
this stage on, BHOB started increasing in the three
groups until treatment began. When removing animals
from fasting, values of these ketone bodies did not show

















Fig. 1 Glycaemia evolution in sheep. Glycaemia (x ± ds) mmol/L obtained in sheep from groups A (glucose and insulin), B (G + PG) and C (corn)
every 12 h from day 130 of pregnancy throughout treatment. Hours: 0 fast starts; 36 fast ends; 48 treatments start
Table 1 Glycaemia evolution in three groups
Hours Group A Group B Group C
0 2.71 ± 0.66 2.95 ± 0.57 3.00 ± 0.59
12 2.08 ± 0.64 2.04 ± 0.84 1.96 ± 0.40
24 1.70 ± 0.74 1.55 ± 0.54 1.67 ± 0.66
36 1.52 ± 0.49 1.49 ± 0.54 1.64 ± 0.55
48 1.41 ± 0.48 1.79 ± 0.75 1.83 ± 0.64
60 2.92 ± 0.64 c 3.26 ± 0.48 a 2.00 ± 0.89 b
72 2.06 ± 0.67 a 3.21 ± 0.58 b 1.98 ± 0.56 a
84 2.48 ± 1.01 2.84 ± 0.48 2.28 ± 1.07
96 2.38 ± 0.54 b 3.62 ± 0.68 c 3.00 ± 0.72
108 3.23 ± 0.89 3.17 ± 0.29 3.06 ± 1.07
120 2.13 ± 0.82 b 3.44 ± 0.61 c 2.94 ± 1.22
132 3.28 ± 1.12 3.20 ± 0.49 2.92 ± 0.64
144 2.70 ± 0.42 a 3.79 ± 0.42 b 3.37 ± 0.03 b
Glycaemia (x ± ds) mmol/L obtained in sheep from group A (glucose and
insulin); B (G + PG) and C (corn) every 12 h from day 130 of pregnancy
throughout the treatment. Statistical differences: a-b: p < 0.001; b-c: p < 0.01
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2.54 ± 0.53 and 2.62 ± 0.,80 mmol/L respectively). BOHB
started decreasing in the three groups, once treatment
began, although the decrease was sharper and earlier in
group B. The differences found between groups A and B
(p < 0.01) and C and B (p < 0.05) started at 48 h from
treatment initiation, remaining like this until treatment
finished. BOHB serum values between groups A and C
however did not show significant differences throughout
treatment (Fig. 2).
No animal showed clinical signs of pregnancy toxaemia
throughout the research, nor during the period of fasting,
nor the phase of treatment.
Discussion
Considering the BOHB and glycaemia values, at the mo-
ment of removing the sheep from fasting and the fact that
there was no evidence of any clinical signs, it is reasonable
to assume that these animals were affected by sub-clinical
pregnancy toxaemia before treatments started [18, 19].
Early diagnosis is very important. The simplest method
is the use of test strips. While it is important to bear in
mind that the test strips used for the pregnancy toxaemia
diagnosis is based on the semi-quantitatively determin-
ation of ketone bodies in urine, nevertheless these stripes
react in presence of acetoacetate and acetone and do not
detect BOHB which is found in larger quantity in this
disease. The positive reaction of these test stripes clearly
indicates the presence of ketonuria. However, there have
recently appeared on the market portable and electronic
devices (FreeStyle®, Precision Xceed®, Precision Xtra®, etc.)
with great field level diagnostic potential, specially for
veterinary clinicians, measuring blood BOHB in sheep
[20], goats [21] or cattle [22]. There has been found a
high correlation between the BOHB and glucose values
measured with these devices and the ones obtained by
the laboratory, showing high sensitivity and specificity
[20, 22].
Taking into account that one of the main objectives
of the treatment for pregnancy toxaemia is the increase
of glycaemia [12, 14, 15, 23], when assessing the results
in this paper we observed that once treatment started
glycaemia began increasing in the three experimental
groups. However, in sheep treated with propylene glycol
and the ones treated with an i.v. infusion of glucose plus
insulin, this increase took place earlier than in sheep
treated with corn supplementation. This difference can be
explained if we consider the different rates of absorption
and conversion of the precursors used into glucose for
treatment in groups A and B. According to Herdt and
Emery [23] an i.v. infusion of glucose immediately causes
an increase in blood glucose concentration resulting in
transient hyperglycaemia, which we did not observe in
our research as a consequence of the insulin subcutaneous
infusion immediately after the glucose infusion, since this
promotes the rapid glucose uptake and utilization by per-
ipheral tissues [14].
Glycaemia increase in response to propylene glycol after
12 h of treatment from 1.79 ± 0.75 to 3.26 ± 0.48 mmol/L.
Propylene glycol, which is mainly absorbed intact directly
from the rumen at a rate of 40 % per hour [23] and reaches
its maximum blood level within 30 min of administration
and maximum blood glucose conversion at about 4 h after
administration. Propylene glycol transformation in glucose
probably occurs via conversion to pyruvate [23].
In this group, blood glucose values were the highest
throughout the treatment. Propylene glycol produces a
rapid increase of glucose, while glycerol is slowly degraded
in the rumen producing a high proportion of propionate,
main precursor of glucose via gluconeogenesis, resulting in
a glycaemia increase for a relatively long period and further-
more, glycerol and propylene glycol treatment was repeated
twice daily according to Rook [5], Wierda et al. [24] and
Sienra et al. [25], all of which can explain glucose behaviour
In the group where fed corn (group C), glycaemia
















Fig. 2 ß-hydroxybutyrate evolution in sheep. ß-hydroxybutyrate (BOHB) (x ± ds) mmol/l obtained from sheep in groups A (glucose and insulin), B
(G + PG), and C (Corn) every 24 h from day 130 of pregnancy until the end of treatments. Hours: 0 fast starting time; 48 treatments starting time
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12 h of the start of the treatment, reaching 3.00 ±
0.72 mmol/L 48 h later. Ruminal microorganisms must
attack the corn and transform it into volatile fatty acids,
especially propionic acid [26, 27], which once formed, has
to be absorbed at ruminal papillae level, being partly
transformed in lactate in the rumen wall and both are
converted into glucose in the liver via neoglucogenesis.
Between 18 and 42 % starch from corn may escape rumen
degradation and be digested in the small intestine [28].
However, only 30 to 35 % of the glucose formed from
starch intestinal digestion, can be found in the portal
vein [29].
The treatment of the sheep with intravenous glucose did
not reach stable glycaemia concentrations, rapid increases
post-administration were produced, followed by important
decreases thereof. González-Montaña et al. [30] and
González-Montaña et al. [31] described this glycaemia
behaviour and attributed it to glucose renal excretion when
it was administered intravenously. Intravenous infusions of
glucose solutions is bound to result in transient hypergly-
cemia leading to diuresis and urinary loss of a large portion
of the administered glucose [23]. Fox [32] established that
after an i.v. infusion of glucose, approximately an 80 % of
the dose is excreted by urine.
Considering that another of the objectives of pregnancy
toxaemia treatment is to restore blood ketone bodies to
normal concentrations [12, 23], results in this research
showed that while blood BOHB decreased in the three
experimental groups, once treatments were implemented,
that decrease was sharper and earlier than in sheep treated
with propylene glycol, and in addition BOHB remained
significantly lower throughout the research. We think that
the fatty acids metabolism was altered suppressing its
mobilization from the adipose tissue, reducing their entry
into the liver and reducing their transformation into
mitochondrias. Propylene glycol increases pyruvate con-
centration with the subsequent oxaloacetate production
via pyruvate carboxylase. Available oxaloacetate increase is
expected to produce an increase in intramitochondrial
citrate concentration. Intramitochondrial citrate escapes
to form malonyl-CoA when is increased, it is a powerful
transformation suppressor of fatty acids into mitochondria
[33–35]. The fatty acids entry reduction into hepatic
mitochondrias results in hepatic ketosis decreasing.
Additionally, glucose supply provided by propylene
glycol treatment may increase the insulin:glucagon
relationship therefore affecting ketosis [23].
Glucose infusion results in a gluconeogenesis reduc-
tion [23], leading to an increase of the Krebs cycle which
intermediates concentration inside the mitochondria due
to the smaller quantity of substrates that are transported
to the cytosol serving as glucose precursors. Citrate is
one of those intermediaries, when increases it also increases
Malonyl-CoA formation [33–35]. Herdt and Emery [23]
also add that a glucose injection may cause a reduction in
glucagon plasma since its secretion decreases in response
to hyperglycaemia.
Increased citrate (and malonyl-CoA) and glucagon
reduction will cause the fatty acid entry reduction inside
the hepatic mitochondria. To these effects in the ketone
bodies synthesis reduction we must add the antiketo-
genic effects of insulin, which was administered together
with the intravenous glucose. The antiketogenic effect of
insulin causes the following actions to occur: 1) it de-
presses the release of fatty acids from adipose tissue; 2)
it promotes the use of ketone bodies in peripheral
tissues; 3) it suppresses the entry of fatty acids to the
liver; 4) relatively low insulin concentrations block the
ketogenic effect of glucagon, thus limiting the fatty acids
entry into the mitochondria [23, 36].
While the three treatments applied were able to restore
blood glucose and BOHB normal concentrations, glycerol
+ propylene glycol treatment was the one, which achieved
the results in less time and it had a more prolonged effect.
Propylene glycol treatment results administered in the
same doses and frequencies as in this research, in animals
with clinical pregnancy toxaemia showed contradictory
results. While Sienra et al. [25] indicated good results and
metabolic parameters normalization, Wierda et al. [24]
only achieved good results in mild forms of the disease,
reporting that in animals with advanced pregnancy toxae-
mia results were poor. Sargison et al. [1] and Brozos et al.
[14] suggested that although given a complete treatment,
only one third of sheep with clinical pregnancy toxae-
mia would probably survive Koenig and Contreras
[37] reported that in sheep induced to toxaemia by
fasting, propylene glycol treatment reduced mortality
in about 50 %. The differences found are explained by
considering Rook’s proposals [5]. This author sug-
gested that precursors compounds of glucose synthesis
in the liver would be useful provided there is no organ
severely compromised. Herdt and Emery [23] added
that the ability to use propylene glycol is reduced in
liver fatty infiltration. According to our findings and
to Marteniuk and Herdt [15], the treatment with propyl-
ene glycol should be initiated as soon as possible, before as
complications of the disease appear (acidosis, irreversible
neurological damage, severe dehydration, kidney failure,
etc.) and the chances of recovery would be lower.
Regarding corn treatment we can make the same sugges-
tion considering the results in this research. Marteniuk and
Herdt [15] stated that sheep in early stages of the disease
and still maintaining their appetite, the energy increase sup-
plied by the starch in the diet would be enough to reverse
the conditions, adding that a more vigorous treatment is
needed when animals are not eating or are eating very little.
This type of treatment would be of practical use in subclin-
ical pregnancy toxaemia cases in a commercial flock.
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Koenig and Contreras [37], Cal Pereyra et al. [10]
and Lima et al. [7] noted that advanced cases of
clinical pregnancy toxaemia caused hyperglycaemia,
thus glucose based therapy would have no effect at that
stage of pregnancy. In spite of this fact, our findings
show that at the early stages of pregnancy, treatment
with intravenous glucose and subcutaneous insulin in
pregnancy toxaemia is useful to reverse the process.
However, according to Rook, [5] in considering the
usage of this treatment, it would be of little practical
use in cases of pregnancy toxaemia in conventional
flocks but it would be justified in individual cases of
the disease, such as in hospitalized and highly repro-
ductive valued animals.
Conclusions
We conclude that all three treatments administered to
sheep affected by sub-clinical pregnancy toxaemia were able
to restore normal blood glucose and ß-hydroxybutyrate
concentrations. We consider that per os administration of
100 ml glycerol together with propylene glycol to each
sheep every 12 h was the most interesting treatment, since
it normalises the aforementioned biochemical parameters
in a shorter period of time.
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